S100A4 exerts proinflammatory action and has been shown to be involved in the pathogenesis of some chronic immune-mediated inflammatory skin diseases, such as psoriasis and systemic sclerosis [16,17,18,19,20]. Here, S100A4 is linked to systemic sclerosis.